LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)

News

Legend Biotech: Undervalued Leader In The CAR-T Race [Seeking Alpha]
Legend Biotech CARVYKTI Milestones Contrast With Mixed Long Term Share Returns [Yahoo! Finance]
Legend Biotech (LEGN) had its "buy" rating reaffirmed by HC Wainwright. They now have a $50.00 price target on the stock.
Why Legend Biotech Stock Crushed the Market on Monday [Globe and Mail, The (Toronto, Canada)]
Why Legend Biotech Stock Crushed the Market on Monday [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com